Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I mostly believe your version because the CEO is the CFO is the Chairman is the ...
Why isn't anyone discussing this $5 million of securities put into a Malik account? Can someone please point me to a post or article which indicates it's been resolved? Thanks in advance.
You'll never know if an entity dropped out of majority status. There's lots of ways to hide it until at least a year goes by.
Yes, "LOL". The stupidity is beyond belief.
"One salary for three. Lol"
The research firm? ....And what about NW?
And what about NW?
And what was the final verdict here?
The research firm, which publishes reports criticizing health-care companies, said Northwest Biotherapeutics Inc. transferred $5 million of securities to a vehicle incorporated by Malik shortly after he published a bullish report on the drug developer.
No, that is NOT a way to save money with a publicly run company. You're talking peanuts considering what's been raised and squandered. Do you have any idea how much investment capital is lost with this sort of suspicious management structure - Many investors will simply pass over it.
Any good reason Woodford allows Powers to wear so many hats?
Is this the collaboration you're referring to? How'd that go?
BETHESDA, Md., March 29, 2011 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO) announced today that it has entered into a collaboration with The Money Channel to increase public and investor awareness of the advantages of immunotherapy for cancer generally, and the potential of NWBT's DCVax® immunotherapy in particular
Who's paying for those "collaborations" and what's come of them so far? Thank you.
So you spoke with Ms. Powers?
From my experience they will say much was learned from the STUDY that could help the next Plll and eventual commercialization. Watch and learn.
I get the sense this Plll has turned into some "signal seeking" study-only, with no chance of commercialization on this pass. This way remaining silent on the subject allows them to continue with the trading game and salaries.
Well, at least shareholders can rest comfortably since the deal was signed off on by all the officers.
Name: Linda F. Powers
Title: President, Chief Executive Officer
(Principal Executive Officer, Principal Financial
Officer and Principal Accounting Officer) and
Chairman of the Board of Directors
Hideous Delaware law. "We have been informed"...Is this standard language or specific to NWBO?
Our Certificate of Incorporation contains certain provisions permitted under the DGCL relating to the liability of directors. These provisions eliminate a director’s personal liability for monetary damages resulting from a breach of fiduciary duty to the fullest extent permitted by the DGCL. Our Bylaws also provide that we must indemnify our directors and officers to the fullest extent permitted by the DGCL and also provide that we must pay expenses, as incurred, to our directors and officers in connection with a legal proceeding to the fullest extent permitted by the DGCL, subject to very limited exceptions.
Insofar as indemnification for liabilities under the Securities Act may be permitted to directors, officers and controlling persons of Northwest Biotherapeutics pursuant to the foregoing provisions or otherwise, we have been informed that, in the opinion of the SEC, indemnification under the Securities Act is against public policy and is unenforceable.
Show me where I'm accusing please?
"For every 10 honest hardworking CEOs and management teams out there there is a Ken Lay (Linda Powers' former CEO when she was VP of Global Finance at Enron) who is defrauding investors.
"The job of the analyst is to balance hope and skepticism and find those investments that result in gains while minimizing losses.
Without a doubt, if DCVax-L works, investors long NWBO will do well. However, based on the situation as we see it, we cannot find the conviction to hold the stock long term. There is a trade to be had here going in to May 2014 with possible DCVax-Direct results at ASCO. But in the long run our view is that DCVax-L will ultimately fail.
Our view of NWBO management would be greatly improved if NWBO would hire a CFO and separate the financial and accounting responsibilities away from the CEO"
-RedAcre Less
I see no such post.
...Now I think I understand why the board chose not to put their names up on the company website.
You must mean CEO, CFO, COB Linda Powers. No reputable board would ever allow this. What a nightmare for shareholders.
Fascinating. Thank you.
Yep, it's a Delaware company. Can someone please fill me in on the latest with this? Thanks.
On December 7, 2015, the Company received a letter on behalf of shareholders demanding to inspect certain corporate books and records pursuant to Section 220 of the Delaware General Corporation Law. The demand letter claimed that its purpose was to investigate: (1) allegedly improper transactions, misconduct, and mismanagement by directors and an officer of the Company; (2) the possible breach of fiduciary duty by certain directors and officers of the Company; and (3) the independence and disinterestedness of the Company’s board, to determine whether a pre-suit demand would be necessary before commencing any derivative action on behalf of the Company. The Company has appointed a special committee of its Board of Directors consisting of independent and disinterested directors to investigate the allegations set forth in the demand letter, as well as the allegations asserted in the litigation summarized above. The Company also is in ongoing discussions with the shareholders demanding corporate books and records.
So against my better judgment I decided to review a filing.
Chris, just what are you pushing here? But do keep analyzing those images. LOL
Date: August 9, 2016
By: /s/ Linda F. Powers
Name: Linda F. Powers
Title: President and Chief Executive Officer
Principal Executive Officer
Principal Financial and Accounting Officer
Try it again. Wasn't Garnick responsible for helping commercialize Avastin?
Fiduciary duty, Chris! This is not a "quasi" private-public company, as some here have outrageously stated. There can be no such thing in America! Any reasonable offer must be presented to shareholders. If it is not then the suitor will come directly to shareholders. Haven't you learned anything from Peregrind?
Well, you're certainly right on the first statement and maybe on the second. But why the obvious glaring omission for something so simple?
I honestly don't think retail shareholders at this level of investing have much of a notion of BOD responsibility to common's or a clear picture of fiduciary responsibility. Back in the day it was a "good old boys club" and difficult to penetrate but now with the Internet there's really no excuse. But Delaware law has hurt shareholders badly. Where is this headquartered?
Chris, you were the one who brought up Director Black. So where are his findings...the suits...the feedback for common shareholders? Seems like it's been a long time now.
Many of Peregrine's "shareholders" didn't find the BOD to be an issue either despite continuous red flag warnings. You see how that went for them.
How about showing some simple curiosity as to why the BOD's doesn't desire their own profiles on the home website?
Are you sure Black isn't there to defend management? Those things do sometimes turn out that way.
Nice. He'd you factor in the investigation into bad behavior that appears to have gone nowhere?
The one that said "This is Peregrine all over again"?
But the lack of Director profiles on their own website doesn't bother you?
...Do you believe they're changing inclusion/exclusion criteria?
Great post, thanks.
What kind of attacks? Looks like the share price is down 90% so it didn't work...From a shareholders perspective that is. Shareholders should be praying for a hostile takeover but you seem to be saying she prevents it. I've been through this before and it doesn't end well for common's - Trust me.
So Powers is Chairman, CEO and CFO?
You've got compliance people rolling over in their graves. What on earth are you talking about "Quasi"? Does this company have a BOD that answers to common shareholders or not?
"This is actually a quasi-public and a quasi-private company since LP has final voting say..."
Or maybe the company is selling shares at 58 cents??